Literature DB >> 17901360

Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme.

Silke Weber1, Dominik Bernhard, Robert Lukowski, Pascal Weinmeister, René Wörner, Jörg W Wegener, Nadejda Valtcheva, Susanne Feil, Jens Schlossmann, Franz Hofmann, Robert Feil.   

Abstract

Smooth muscle expresses the Ialpha and the Ibeta isoforms of cGMP-dependent protein kinase I (cGKI). Inactivation of the murine cGKI gene prkg1 leads to multiple phenotypes and premature death at approximately 6 weeks. We reconstituted mice with the cGKIalpha or -Ibeta isozyme to test which isozyme was needed to support basic smooth muscle functions. Mice were generated by gene targeting. The cGKIalpha or the -Ibeta coding sequences were placed under the control of the SM22alpha promoter to express either isoform selectively in smooth muscle cells (SM-Ialpha or SM-Ibeta transgene). To generate smooth muscle-specific cGKIalpha or cGKIbeta rescue mice, the SM-Ialpha or SM-Ibeta transgenes were crossed on a cGKI-/- genetic background. The levels of cGKIalpha or -Ibeta expression were comparable to endogenous cGKI expression in wild-type aortic and intestinal smooth muscles. In cGKIalpha or -Ibeta rescue mice, expression of the isozymes was not detectable in non-smooth muscle tissues and cells. Median survival time of the Ialpha and Ibeta rescue mice was 52 weeks. Both isozymes mediated the 8-bromo-cGMP-induced relaxation of precontracted jejunum and aorta muscle strips. Activation of both isozymes reduced hormone- or K+-induced [Ca2+]i levels. The cGKIalpha and cGKIbeta rescue mice did not show a significant difference in intestinal passage time of BaSO4 in comparison with wild-type animals. Telemetric blood pressure measurements in conscious freely moving animals did not show differences between rescues and control mice in basal blood pressure and its regulation by DETA-NO, sodium nitroprusside, carbachol, or Y-27632. These results show that cGKI in smooth muscle is essential and that either cGKI isozyme alone can rescue basic vascular and intestinal smooth muscle functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901360     DOI: 10.1161/CIRCRESAHA.107.154351

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Iron deficiency anemia in cyclic GMP kinase knockout mice.

Authors:  Elisabeth Angermeier; Katrin Domes; Robert Lukowski; Jens Schlossmann; Birgit Rathkolb; Martin Hraběde Angelis; Franz Hofmann
Journal:  Haematologica       Date:  2016-02       Impact factor: 9.941

3.  Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5.

Authors:  Manling Zhang; Eiki Takimoto; Steven Hsu; Dong I Lee; Takahiro Nagayama; Thomas Danner; Norimichi Koitabashi; Andreas S Barth; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Am Coll Cardiol       Date:  2010-10-21       Impact factor: 24.094

4.  Pregnancy modifies the large conductance Ca2+-activated K+ channel and cGMP-dependent signaling pathway in uterine vascular smooth muscle.

Authors:  Charles R Rosenfeld; Xiao-tie Liu; Kevin DeSpain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06       Impact factor: 4.733

5.  cGMP-dependent protein kinase I in vascular smooth muscle cells improves ischemic stroke outcome in mice.

Authors:  Maria Shvedova; Maxim M Litvak; Jesse D Roberts; Dai Fukumura; Tomoaki Suzuki; İkbal Şencan; Ge Li; Paula Reventun; Emmanuel S Buys; Hyung-Hwan Kim; Sava Sakadžić; Cenk Ayata; Paul L Huang; Robert Feil; Dmitriy N Atochin
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-18       Impact factor: 6.200

6.  Feeding-Related Traits Are Affected by Dosage of the foraging Gene in Drosophila melanogaster.

Authors:  Aaron M Allen; Ina Anreiter; Megan C Neville; Marla B Sokolowski
Journal:  Genetics       Date:  2016-12-22       Impact factor: 4.562

7.  Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.

Authors:  Veronika Wetzl; Elisabeth Schinner; Frieder Kees; Lothar Faerber; Jens Schlossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-28       Impact factor: 3.000

8.  cGMP-dependent protein kinase anchoring by IRAG regulates its nuclear translocation and transcriptional activity.

Authors:  Darren E Casteel; Tong Zhang; Shunhui Zhuang; Renate B Pilz
Journal:  Cell Signal       Date:  2008-03-26       Impact factor: 4.315

9.  Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.

Authors:  Michael Klaiber; Martin Kruse; Katharina Völker; Juliane Schröter; Robert Feil; Marc Freichel; Andrea Gerling; Susanne Feil; Alexander Dietrich; Juan Eduardo Camacho Londoño; Hideo A Baba; Joel Abramowitz; Lutz Birnbaumer; Josef M Penninger; Olaf Pongs; Michaela Kuhn
Journal:  Basic Res Cardiol       Date:  2010-03-30       Impact factor: 17.165

10.  cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake.

Authors:  Jennifer A Steiner; Ana Marin D Carneiro; Jane Wright; Heinrich J G Matthies; Harish C Prasad; Christian K Nicki; Wolfgang R Dostmann; Carrie C Buchanan; Jackie D Corbin; Sharron H Francis; Randy D Blakely
Journal:  Mol Brain       Date:  2009-08-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.